Table 3
Open in new tab

Treatment-emergent adverse events, incidence >5% in either group

OFC, Olanzapine/fluoxetine combination; Lam, lamotrigine.

Table 3
Open in new tab

Treatment-emergent adverse events, incidence >5% in either group

OFC, Olanzapine/fluoxetine combination; Lam, lamotrigine.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close